Trastuzumab continues to show significantly improved overall and disease-free surviva

[News]

After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free...

More... (http://www.medicalnewstoday.com/releases/284169.php)